Compare BYND & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BYND | CYRX |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.7M | 419.3M |
| IPO Year | 2018 | 2008 |
| Metric | BYND | CYRX |
|---|---|---|
| Price | $0.56 | $15.37 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $0.83 | ★ $13.31 |
| AVG Volume (30 Days) | ★ 31.9M | 747.6K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.69 | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $275,496,000.00 | $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $1.36 | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $6.69 |
| 52 Week High | $7.69 | $16.89 |
| Indicator | BYND | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 30.64 | 48.83 |
| Support Level | $0.50 | $14.51 |
| Resistance Level | $0.82 | $16.76 |
| Average True Range (ATR) | 0.03 | 0.80 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 7.88 | 40.09 |
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.